Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 4Terminated 3Unknown 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 2

Conditions

Venous Thrombosis 3Neoplasms 3Venous Thromboembolism 2Thrombosis 1Soft Tissue Neoplasms 1Pulmonary Embolism 1Pancreatic Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Catheter-Related Infections 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 34pembrolizumab 26Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Enoxaparin × Clear all
NCT00633061 2020-10-08

DVT

University of Texas Southwestern Medical Center

Phase 2 Terminated
136 enrolled 6 charts

Neoplasms, Venous Thrombosis, Catheter-Related Infections

NCT01817257 2018-10-29

ALICAT

Cardiff University

Phase 2 Terminated
2 enrolled
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT01164046 2014-12-03

Longheva

University Medical Center Groningen

Phase 3 Terminated
56 enrolled
Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡